Background Anxiety and related disorders are among the most common mental disorders,
with lifetime prevalence reportedly as high as 31%. Unfortunately, anxiety disorders are …

Anxiety disorders, as a group, are among the most common mental health conditions and
frequently cause significant functional impairment. Both psychotherapeutic and …

In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002,
World J Biol Psychiatry 3: 171), recommendations for the pharmacological treatment of …

Pharmacotherapy for post traumatic stress disorder (PTSD) - Stein, DJ - 2006 | Cochrane
Library Skip to Content Cookies Our site uses cookies to improve your experience. You can …

A large proportion of humans will experience a traumatic event at least once in their lifetime,
with up to 10% then going on to developing posttraumatic stress disorder (PTSD). In this …

Rationale Chronic social defeat stress (CSDS) has been proposed as a model of
depression. However, most CSDS studies rely only on the analysis of stress-induced social …

published in October 2004. Since that time, a number of well-designed randomized
controlled trials of pharmacological and psychotherapeutic interventions for posttraumatic …

Depression is a debilitating chronic illness that affects around 350 million people worldwide.
Current treatments, such as selective serotonin reuptake inhibitors, are not ideal because …

Understanding the neurobiological mechanisms of post-traumatic stress disorder (PTSD) is
of vital importance for developing biomarkers and more effective pharmacotherapy for this …

There is currently no uniform definition of treatment response for posttraumatic stress
disorder (PTSD) to guide researchers and clinicians in the area of posttraumatic mental …